Drugs and Devices

FDA advises women with breast impants

The U.S. Food and Drug Administration says women with breast implants may have a “very small, but increased risk” of developing anaplastic large cell lymphoma (ALC). The FDA adds that “the known ALCL cases are too few to say conclusively that breast implants cause the disease.” Read more at http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm240985.htm and http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm241086.htm.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Newsletter Subscribe

  • This field is for validation purposes and should be left unchanged.

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares